Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, UK.
J Neurol Neurosurg Psychiatry. 2010 Mar;81(3):267-70. doi: 10.1136/jnnp.2009.171926. Epub 2009 Oct 13.
Cognition is affected early in Huntington disease (HD), and in HD animal models there is evidence that this reflects abnormal synaptic plasticity. The authors investigated whether there is any evidence for abnormal synaptic plasticity using the human motor cortex-rTMS model and, if so, if there is any difference between premanifest HD gene carriers and very early manifest HD patients or any relationship with ratings of the severity of motor signs.
Fifteen HD gene carriers (seven premanifest, eight very early manifest) and 14 control participants were given a continuous train of 100 bursts of theta burst stimulation (cTBS: three pulses at 50 Hz and 80% AMT repeated every 200 ms). The size of the motor-evoked potential was measured at regular intervals until 21 min after cTBS.
HD gene carriers and controls responded differently to theta burst stimulation (F(4.9,131.9)=1.37, p=0.048) with controls having more inhibition than HD gene carriers (F(1,27)=13.3, p=0.001). Across all time points, mean inhibition differed between the groups (F(2,26)=6.32, p=0.006); controls had more inhibition than either HD gene carrier subgroup (p=0.006 for premanifest and p=0.009 for early symptomatic), whereas there was no difference between premanifest and early symptomatic HD gene carriers. The measure of cortical plasticity was not associated with any clinical ratings (Unified Huntington Disease Rating Scale motor score, estimate of age at onset).
Motor cortex plasticity is abnormal in HD gene carriers but is not closely linked to the development of motor signs of HD.
认知功能在亨廷顿病(HD)的早期就受到影响,在 HD 动物模型中,有证据表明这反映了异常的突触可塑性。作者研究了使用人类运动皮层-rTMS 模型是否存在异常突触可塑性的证据,如果存在,那么在无症状 HD 基因携带者和早期症状性 HD 患者之间是否存在任何差异,或者与运动症状严重程度的评分是否存在任何关系。
15 名 HD 基因携带者(7 名无症状,8 名早期症状)和 14 名对照参与者接受了 100 次 theta 爆发刺激(cTBS:50 Hz 下的三个脉冲,80% AMT,每 200 ms 重复一次)的连续训练。在 cTBS 后 21 分钟内定期测量运动诱发电位的大小。
HD 基因携带者和对照者对 theta 爆发刺激的反应不同(F(4.9,131.9)=1.37,p=0.048),对照者的抑制作用强于 HD 基因携带者(F(1,27)=13.3,p=0.001)。在所有时间点,组间平均抑制作用均有差异(F(2,26)=6.32,p=0.006);与任何一个 HD 基因携带者亚组相比,对照组的抑制作用更强(无症状组 p=0.006,早期症状组 p=0.009),而无症状和早期症状的 HD 基因携带者之间则没有差异。皮质可塑性的测量值与任何临床评分(统一亨廷顿病评定量表运动评分,发病年龄估计)均无关。
HD 基因携带者的运动皮层可塑性异常,但与 HD 运动症状的发展关系不大。